KevinScottBakerMD
Pediatric Hematology & Oncology • Seattle, WAPediatric Hematologic Oncology
Professor, Pediatrics, University of Washington School of Medicine and Co-Interim Division Chief, Hematology-Oncology, Seattle Children’s Hospital
Dr. Baker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5307
Education & Training
Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 1991 - 1994
University of Nebraska Medical Center College of MedicineResidency, Pediatrics, 1988 - 1991
University of Nebraska College of MedicineClass of 1988
Certifications & Licensure
WA State Medical License 2009 - 2026
ID State Medical License 2022 - 2025
PA State Medical License 2022 - 2024
MN State Medical License 1998 - 2010
OH State Medical License 1991 - 1994- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
- Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies Start of enrollment: 2015 Mar 01
Publications & Presentations
PubMed
- 30 citationsLate health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group.Eric J. Chow, Richard Aplenc, Lynda M. Vrooman, David R. Doody, Yuan-Shung Huang
Cancer. 2021-10-13 - 34 citationsSubsequent Malignant Neoplasms after Hematopoietic Cell TransplantationGérard Socié, K. Scott Baker, Smita Bhatia
Biology of Blood and Marrow Transplantation. 2012-01-01 - 110 citationsBusulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: A Population Pharmacokinetic Model for Initial and Bayesian Dose PersonalizationJeannine S. McCune, Meagan J. Bemer, Jeffrey S. Barrett, K. Scott Baker, Alan S. Gamis
Clinical Cancer Research. 2014-02-01
Journal Articles
- Reduced Intensity Conditioning for Hematopoietic Cell Transplant for HLH and Primary Immune Deficiencies: BMT CTN 1204Shalini Shenoy, K Scott Baker, Elizabeth O Stenger, Mary Eapen, Carl Allen, Lauri Burroughs, Philip Roehrs, Catherine M Bollard, Rabi Hanna, Jeffrey R Andolina, James ..., Blood
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
